Clinical Trials
3 trialsNCT01880515 2025-05-11
Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib)
Instituto Nacional de Cancerologia de Mexico
Phase 2 Completed
NCT00473083 2017-04-04
LUTRAERL
British Columbia Cancer Agency
Phase 2 Completed
NCT00343187 2011-05-30
A Phase II Study of ACZONE™ (Dapsone) Gel, 5% As a Treatment For Tarceva® (Erlotinib)Related Rash
Allergan
Phase 2 Terminated